NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
1.590
+0.100 (6.71%)
At close: Apr 1, 2026, 4:00 PM EDT
1.590
0.00 (0.00%)
After-hours: Apr 1, 2026, 8:00 PM EDT

NovaBay Pharmaceuticals Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
42.33M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 202310.46M-3.95M-27.42%
Dec 31, 202214.40M4.20M41.16%
Dec 31, 202110.20M270.00K2.72%
Dec 31, 20209.93M3.34M50.54%
Dec 31, 20196.60M-5.91M-47.24%
Dec 31, 201812.51M-5.72M-31.39%
Dec 31, 201718.23M6.33M53.23%
Dec 31, 201611.90M7.52M171.56%
Dec 31, 20154.38M3.33M315.65%
Dec 31, 20141.05M-2.42M-69.69%
Dec 31, 20133.48M--
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 20109.75M-5.93M-37.81%
Dec 31, 200915.68M8.96M133.32%
Dec 31, 20086.72M809.00K13.68%
Dec 31, 20075.91M4.38M285.71%
Dec 31, 20061.53M--
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Atara Biotherapeutics120.77M
Nutriband2.28M
RenovoRx1.12M
Rallybio858.00K
Lisata Therapeutics170.00K
Revenue Rankings